KT Tape, a company that deals with drug-free pain relief, has launched its KT Recovery+ Wave, it was reported on Monday.
The company says that the product is a clinically proven and FDA approved wearable device that offers drug-free pain relief for sports injuries, knee pain, arthritis, back pain, carpal tunnel, sprains and more.
The new KT Recovery+ Wave utilises sensation-free electromagnetic pulses called pulsed shortwave therapy to decrease nerve hypersensitivity and relieve pain. It has a guaranteed battery life of 250 hours and is available at an MSRP of USD34.99.
SK Biopharmaceuticals signs licence agreement with Wisconsin Alumni Research Foundation
GE HealthCare receives FDA clearance for AI-powered Pristina Recon DL mammography system
Remington Medical's VascuChek 2.0 Cordless Bluetooth-Enabled Doppler Secures FDA Clearance
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Curasight begins phase 1 trial of uTREAT in glioblastoma
Prestige Biopharma agrees Tuznue licence and supply deal for Latin America
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
Novo Nordisk reports strong phase 2 results for amycretin in type 2 diabetes
Active Biotech to receive US patent for tasquinimod formulation
Sanofi and Regeneron's Dupixent approved in EU for chronic spontaneous urticaria
Blacksmith Medicines granted European patent for LpxC-targeting antibacterial compounds
Xenogenic Materials Demonstrate Promising Results in Peri-Implantitis Management
LivaNova secures higher Medicare reimbursement for VNS Therapy procedures